{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-000072","form_type":"8-K","ticker":"QTZM","cik":"0001663038","company_name":"Quantum Genesis AI Corp.","filed_at":"2026-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.804802+00:00","generated_at":"2026-05-16T11:22:36.354758+00:00","sec_items":["5.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Quantumzyme Corp. changing name to Quantum Genesis AI Corp., pending regulatory approvals","bullets":["Board approved name change to Quantum Genesis AI Corp. on Nov 30, 2025; majority shareholder consented.","Certificate of Amendment not yet filed; effective after SEC 14C process and 20-day waiting period.","FINRA notification filed; new ticker symbol to be assigned upon completion of review.","Name change does not affect shareholder rights, authorized shares, par value, or CUSIP."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-000072","json":"https://secwatch.observer/filing/0001477932-26-000072.json","markdown":"https://secwatch.observer/filing/0001477932-26-000072.md","text":"https://secwatch.observer/filing/0001477932-26-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/qtzm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:22:36.354758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"75b216662410a503578ca8950c8de9fcdc09d6e1","claim":"Quantum Genesis AI Corp.: Amended Articles of Incorporation to change company name from Quantumzyme Corp. to Quantum Genesis AI Corp (effective 2025-11-30).","evidence_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001628280-26-039465","ticker":"IOT","company_name":"Samsara Inc.","filed_at":"2026-06-01T20:07:41+00:00","headline":"Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039465","json":"https://secwatch.observer/filing/0001628280-26-039465.json","markdown":"https://secwatch.observer/filing/0001628280-26-039465.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/iot-20260601.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm"}},{"accession":"0000943374-26-000219","ticker":"DCOM","company_name":"Dime Community Bancshares, Inc. /NY/","filed_at":"2026-06-01T20:02:33+00:00","headline":"Dime Commercial Bancshares name change effective; three executives amend employment agreements","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000219","json":"https://secwatch.observer/filing/0000943374-26-000219.json","markdown":"https://secwatch.observer/filing/0000943374-26-000219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/form8k_052826.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"Subsequent to the approval by its shareholders at the Extension Meeting of Rising Dragon’s second amended and restated memorandum and articles of association (the “Amended Charter”), the Company filed the Amended Charter with the Cayman Islands Registrar of Companies, effective May 28, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm"}},{"accession":"0001213900-26-062808","ticker":"FFAI","company_name":"FARADAY FUTURE INTELLIGENT ELECTRIC INC.","filed_at":"2026-05-29T20:05:36+00:00","headline":"Faraday Future increases authorized common shares 45% to 452.8M, preferred 45% to 34.9M","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062808","json":"https://secwatch.observer/filing/0001213900-26-062808.json","markdown":"https://secwatch.observer/filing/0001213900-26-062808.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1805521/000121390026062808/0001213900-26-062808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1805521/000121390026062808/ea0292663-8k_faraday.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"On May 27, 2026, prior to the Company’s filing of the Certificate of Amendment with the office of the Delaware SOS, the Company filed a Certificate of Elimination (the “Certificate of Elimination”) with the Delaware SOS with respect to the Company’s Series A Preferred Stock, par value $0.0001 per share (“FFAI Series A Preferred Stock”), following the automatic redemption of all outstanding shares of FFAI Series A Preferred Stock after the conclusion of the Company’s Annual Meeting.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1805521/000121390026062808/0001213900-26-062808-index.htm"}},{"accession":"0002077096-26-000185","ticker":"RGR","company_name":"STURM RUGER & CO INC","filed_at":"2026-05-28T21:12:42+00:00","headline":"Sturm Ruger stockholders approve increase in authorized common shares from 40M to 60M","event_type":"other_material","sec_items":["5.03","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0002077096-26-000185","json":"https://secwatch.observer/filing/0002077096-26-000185.json","markdown":"https://secwatch.observer/filing/0002077096-26-000185.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/95029/000207709626000185/0002077096-26-000185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/95029/000207709626000185/ea0292589-8k_sturm.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"On May 27, 2026, the Company’s stockholders approved an amendment (the “ Charter Amendment ”) to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, par value $1.00 per share (the “ Common Stock ”) to 60 million shares. The Charter Amendment became effective upon its filing with the Secretary of State of the State of Delaware on May 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/95029/000207709626000185/0002077096-26-000185-index.htm"}},{"accession":"0001213900-26-061794","ticker":"DAIC","company_name":"CID Holdco, Inc.","filed_at":"2026-05-28T12:35:20+00:00","headline":"CID HoldCo (Dot Ai) implements 1-for-25 reverse stock split effective May 29, 2026","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061794","json":"https://secwatch.observer/filing/0001213900-26-061794.json","markdown":"https://secwatch.observer/filing/0001213900-26-061794.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/0001213900-26-061794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/ea0292442-8k_cidhold.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information set forth in Item 3.03 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 5.03. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/0001213900-26-061794-index.htm"}},{"accession":"0000356171-26-000079","ticker":"TCBK","company_name":"TRICO BANCSHARES /","filed_at":"2026-05-28T01:34:00+00:00","headline":"TriCo Bancshares annual meeting: cumulative voting eliminated, directors elected","event_type":"other_material","sec_items":["5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000356171-26-000079","json":"https://secwatch.observer/filing/0000356171-26-000079.json","markdown":"https://secwatch.observer/filing/0000356171-26-000079.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/0000356171-26-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/tcbk-20260521.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm","comparable_excerpt":"the Board implemented the Amendment by adopting and approving amended and restated bylaws","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/0000356171-26-000079-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}